Remember Intuitive Surgical's rise of 18,000% over two decades? It used new tech to transform surgery.
Now, I've found an obscure AI stock following its path.
This company brought the first AI-designed drug to clinical trials. It's lined up major pharma partnerships together worth over $7 billion.
Yet with a market cap of only $700 million, it trades for under $10 a share.
My new video reveals why this little-known leader in AI drug discovery could hand investors incredible profits in the years ahead.
[[Click here for the details.]]
Good investing,
Alexander Green
Chief Investment Strategist, The Oxford Club
This ad is sent on behalf of The Oxford Club, 105 W. Monument Street Baltimore, MD 21201. If you would like to opt out from receiving offers from The Oxford Club, please click here
This offer is brought to you by StockGuru LLC. 2563 Cherry Hill Ln Hermitage PA 16148. If you would like to unsubscribe from receiving offers brought to you by StockGuru LLC click below.
|
No comments:
Post a Comment